# Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer

> **NCT00322920** · PHASE1 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 30 (estimated)

## Conditions studied

- Cervix Cancer

## Interventions

- **DRUG:** Topotecan
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT00322920
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** Low accrual
- **Last updated:** 2008-02-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00322920

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00322920, "Efficacy Study of Weekly Topotecan With Cisplatin in Advanced Stage or Recurrent Cervical Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00322920. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*